Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Jefferies Reiterates Buy Rating on AVGO, $550 Price Target

Jefferies Reiterates Buy Rating on AVGO, $550 Price Target

BlockBeatsBlockBeats2026/06/30 09:37

BlockBeats News, June 30th: Jefferies analyst Blayne Curtis reiterated a Buy rating on AVGO and set a $550 price target, noting that the recent stock price pullback has created a buying opportunity, with 2028 fiscal year EPS potentially reaching $30-40.


The analyst emphasized that Broadcom's TPU roadmap is progressing as planned, with a long-term agreement with Google until 2031 ensuring minimum revenue, while concerns about MTK's competition have been overemphasized.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race

Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.

智通财经•2026/11/12 01:07

Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity

Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.

智通财经•2026/11/12 01:01
Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity